John Walter Hanna's most recent trade in Caredx Inc was a trade of 61,469 Common Stock done at an average price of $19.2 . Disclosure was reported to the exchange on April 15, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Caredx Inc | John Walter Hanna | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.16 per share. | 15 Apr 2025 | 61,469 | 627,041 (1%) | 0% | 19.2 | 1,177,746 | Common Stock |
| Caredx Inc | John Walter Hanna | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2025 | 200,706 | 688,510 (1%) | 0% | 0 | Common Stock | |
| Veracyte Inc | John Walter Hanna | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 55.08 per share. | 02 Dec 2020 | 465 | 73,844 (0%) | 0% | 55.1 | 25,612 | Common Stock |
| Veracyte Inc | John Walter Hanna | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.21 per share. | 06 Nov 2020 | 21,250 | 95,559 (0%) | 0% | 20.2 | 429,463 | Common Stock |
| Veracyte Inc | John Walter Hanna | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Nov 2020 | 21,250 | 38,750 | - | - | Stock Option (right to buy) | |
| Veracyte Inc | John Walter Hanna | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 43.40 per share. | 06 Nov 2020 | 20,050 | 75,509 (0%) | 0% | 43.4 | 870,076 | Common Stock |
| Veracyte Inc | John Walter Hanna | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 44.19 per share. | 06 Nov 2020 | 1,200 | 74,309 (0%) | 0% | 44.2 | 53,031 | Common Stock |
| Veracyte Inc | John Walter Hanna | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 05 Nov 2020 | 3,613 | 77,102 (0%) | 0% | 40.0 | 144,506 | Common Stock |
| Veracyte Inc | John Walter Hanna | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.98 per share. | 05 Nov 2020 | 3,281 | 80,715 (0%) | 0% | 6.0 | 19,620 | Common Stock |
| Veracyte Inc | John Walter Hanna | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Nov 2020 | 3,281 | 20,782 | - | - | Stock Option (right to buy) | |
| Veracyte Inc | John Walter Hanna | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.05 per share. | 05 Nov 2020 | 3,125 | 77,434 (0%) | 0% | 9.0 | 28,281 | Common Stock |
| Veracyte Inc | John Walter Hanna | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Nov 2020 | 3,125 | 7,292 | - | - | Stock Option (right to buy) | |
| Veracyte Inc | John Walter Hanna | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 41.56 per share. | 05 Nov 2020 | 2,660 | 74,442 (0%) | 0% | 41.6 | 110,548 | Common Stock |
| Veracyte Inc | John Walter Hanna | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 42.08 per share. | 05 Nov 2020 | 133 | 74,309 (0%) | 0% | 42.1 | 5,597 | Common Stock |
| Veracyte Inc | John Walter Hanna | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.16 per share. | 02 Sep 2020 | 325 | 74,309 (0%) | 0% | 34.2 | 11,102 | Common Stock |